Eli Lilly and Co (LLY)

LLY (NYSE:Drugs) EQUITY
$78.15
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | LLY Avg Daily Volume: 4,117,800
Last Update: 06/29/16 - 4:02 PM EDT
Volume: 0
YTD Performance: -7.25%
Open: $0.00
Previous Close: $78.15
52 Week Range: $67.88 - $92.85
Oustanding Shares: 1,103,837,002
Market Cap: 82,953,350,700
6-Month Chart
TheStreet Ratings Grade for LLY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 9 9 9
Moderate Buy 0 0 0 0
Hold 4 4 4 3
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.92 1.86 1.86 1.77
Latest Dividend: 0.51
Latest Dividend Yield: 2.71%
Dividend Ex-Date: 08/11/16
Price Earnings Ratio: 34.63
Price Earnings Comparisons:
LLY Sector Avg. S&P 500
34.63 34.50 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
9.00% -6.72% 59.10%
GROWTH 12 Mo 3 Yr CAGR
Revenue 1.70 -0.10 -0.04
Net Income 0.70 -0.40 -0.16
EPS 1.60 -0.40 -0.15
Earnings for LLY:
EBITDA 4.48B
Revenue 19.96B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $0.85 $0.92 $3.57 $3.99
Number of Analysts 7 5 10 10
High Estimate $0.90 $0.96 $3.60 $4.24
Low Estimate $0.80 $0.83 $3.54 $3.71
Prior Year $0.90 $0.89 $3.43 $3.57
Growth Rate (Year over Year) -5.24% 3.82% 4.08% 11.68%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
This is the group that is the most dangerous politically.
Our quantitative service has upgraded the drug maker to a buy, but the technicals are not ready yet to join in.
Update
May 24, 2016 | 7:25 AM EDT
LLY - Eli Lilly and Co Investment Community R&D Update Meeting (Session 1) - 10AM New York City, NY
FDA decision will impact Relypsa's buyout potential while Aritana won't stay this undervalued.
Update
May 11, 2016 | 7:13 AM EDT
Bank of America Merrill Lynch Health Care Conference (Day 2 of 3) - 05/10/16 - 05/12/16 Las Vegas, NV
Update
May 02, 2016 | 7:18 AM EDT
LLY - Eli Lilly and Co Annual Shareholders Meeting - 11AM
Investing in small-cap names take a lot of research and patience, but they can also be very rewarding.

Intermediate Trade: Eli Lilly Real Money Pro($)

Consider the LLY out-of-the-money, bearishly biased vertical put spread expiring in May.

Columnist Conversations

As of 10:19 PM the three major index futures were all slightly positive. It is so close to neutral that anythi...
Travelers is working on an impressive breakout today.  The stock is up just over 2.1% as it extends the rebou...
There is just not much to get excited about when looking at individual stock charts. I scanned about 80 diffe...
General Mills (GIS) surprised investors with a much better than expected 4th quarter today. Revenues were bett...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.